On 21 March 2020 at the start of the COVID-19 measures, the Government issued guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from COVID-19. This included people with cancers of the blood or bone marrow, such as lymphomas, who are at any stage of treatment. It also included all WM patients.
Patients in this category were advised by letters and text messages to self-isolate for 12 weeks in order to protect themselves. This guidance runs to the end of June.
On 11 May 2020, the Government announced its plans for a roadmap for easing lockdown. However, the shielding recommendations for people classed as extremely vulnerable remain unchanged. We await further advice from the Government on this and whether the shielding advice will be extended beyond the end of June.
WMUK advises that shielding for all WM patients should continue until we know more from the Government; and we recommend that all WM patients who receive a letter / text should follow the guidance and to discuss any questions about your treatment and care with your consultant / health care team.
It should be noted that the general advice we are giving is relating to NHS England, and that the devolved nations have different processes, especially Scotland. Links to government advice, information for health professionals and advice for other parts of the UK can be found here.
For further advice about coronavirus (COVID-19) for people with WM please visit our related pages below.